Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients-Reference-Cited by-同舟云学术

Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients

Published:2024-04 Issue:8 Volume:17 Page:979-988
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Kleiman Neal S.,Van Mieghem Nicolas M.,Reardon Michael J.,Gada Hemal,Mumtaz Mubashir,Olsen Peter Skov,Heiser John,Merhi William,Chetcuti Stanley,Deeb G. Michael,Chawla Atul,Kiaii Bob,Teefy Patrick,Chu Michael W.A.,Yakubov Steven J.,Windecker Stephan,Althouse Andrew D.,Baron Suzanne J.^ORCID

Funder

Medtronic Inc

Publisher

Elsevier BV

Reference31 articles.

1. Transcatheter aortic-valve replacement in low-risk patients at five years;Mack;N Engl J Med,2023

2. Five-year outcomes of transcatheter or surgical aortic-valve replacement;Makkar;N Engl J Med,2020

3. 5-Year outcomes of self-expanding transcatheter versus surgical aortic valve replacement in high-risk patients;Gleason;J Am Coll Cardiol,2018

4. 4-Year outcomes of patients with aortic stenosis in the Evolut Low Risk Trial;Forrest;J Am Coll Cardiol,2023

5. Health status benefits of transcatheter vs surgical aortic valve replacement in patients with severe aortic stenosis at intermediate surgical risk: results from the PARTNER 2 randomized clinical trial;Baron;JAMA Cardiol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Economic Consequences of Delayed Transcatheter Aortic Valve Replacement;Structural Heart;2024-06

2. Beyond Mortality;JACC: Cardiovascular Interventions;2024-04